MKSITechnology · Scientific & Technical InstrumentsThe 14 Wall Street analysts covering MKS, Inc. hold a median 12-month price target of $425 — +63.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 90 of 100 as at 5 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores MKS, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (98): Analysts have, on balance, been raising their forecasts.
Volatility (40): The share price moves around a lot.
Size (11): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on MKSI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +63.3% from it.
Of the 20 most recent actions, 7 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 25 Aug 2026 | Mizuho | Maintains | Outperform | $360 → $330 |
| 7 Aug 2026 | Citigroup | Maintains | Buy | — |
| 7 Aug 2026 | Citigroup | Maintains | Buy | $425 → $430 |
| 7 Aug 2026 | JP Morgan | Maintains | Overweight | $365 → $380 |
| 7 Aug 2026 | JP Morgan | Maintains | Overweight | — |
| 7 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 7 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | $300 → $325 |
| 6 Aug 2026 | Needham | Maintains | Buy | $360 → $390 |
| 6 Aug 2026 | Needham | Maintains | Buy | — |
| 3 Aug 2026 | Cantor Fitzgerald | Reiterates | Overweight | — |
| 3 Aug 2026 | Cantor Fitzgerald | Reiterates | Overweight | $600 |
| 24 July 2026 | Citigroup | Maintains | Buy | $355 → $425 |
| 24 July 2026 | Citigroup | Maintains | Buy | — |
| 9 July 2026 | Mizuho | Maintains | Outperform | — |
| 9 July 2026 | Mizuho | Maintains | Outperform | $400 → $415 |
| 6 July 2026 | Morgan Stanley | Maintains | Overweight | — |
| 6 July 2026 | Morgan Stanley | Maintains | Overweight | $374 → $442 |
| 30 June 2026 | BMO Capital | Initiates | Outperform | — |
| 29 June 2026 | Cantor Fitzgerald | Maintains | Overweight | — |
| 29 June 2026 | Keybanc | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MKSI appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Sept 2026, MKS, Inc. returned +157.0% against +20.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 18% of US stocks
Cheaper than 31% of US stocks
Cheaper than 18% of US stocks
Cheaper than 16% of US stocks
Higher than 77% of US stocks
Higher than 89% of US stocks
Higher than 59% of US stocks
Higher than 80% of US stocks
Higher than 70% of US stocks
Higher than 75% of US stocks
Higher than 76% of US stocks
Higher than 7% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
MKS, Inc. has a market value of $17.6B and an enterprise value of $21.2B.
Revenue in the twelve months to 30 June 2026: $4.3B. The latest quarter grew 28.3% year on year.
Net income over the same four quarters: $440.0M, a 10.1% net margin.
Diluted earnings per share, trailing twelve months: $6.27.
Free cash flow in the twelve months to 30 June 2026: $455.0M.
MKS, Inc. spent $0.0 on share buybacks and $63.0M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 41.5×; forward P/E: 14.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.38%, paying out 15% of earnings.
MKS, Inc. employs 10,200 people — $426K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own MKS, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
MKS Instruments (MKSI) reported earnings 30 days ago, and its stock has declined 14.3% since that report. The article examines what might come next for the company's shares.
Why it matters — MKSI watchers would care because the 14.3% post-earnings decline reflects investor reaction to the company's latest results and could signal the direction the stock may take.
Zacks Investment Research published an article comparing MKS Instruments (MKSI) with Hoya Corp. (HOCPY) in the electronics-miscellaneous products sector to determine which stock presents the better value opportunity. The piece frames the comparison around which of the two offers the stronger value prospect for investors.
Why it matters — The article places MKSI in a side-by-side value comparison with a competitor, which MKSI watchers would note as it speaks to how the stock is being evaluated in the market.
Zacks Investment Research highlights MKS (MKSI) as a top growth stock for the long term, using the Zacks Style Scores feature of its Premium research service to identify strong stocks for value, growth, and momentum investors.
Why it matters — A MKSI watcher would care because an analyst research service is presenting the company as a strong long-term growth stock, reinforcing positive investor attention.
MKS shares have begun gaining and may continue moving higher in the near term, driven by solid upward revisions to earnings estimates, according to Zacks Investment Research.
Why it matters — A watcher of MKSI would care because upward earnings estimate revisions are often seen as a favorable signal for the stock's near-term outlook.
Wall Street analysts' average price targets for MKS (MKSI) suggest a potential upside of 49.8%, according to Zacks Investment Research. The article notes that while the reliability of this metric is questionable, the positive trend in earnings estimate revisions could translate into stock upside.
Why it matters — MKSI watchers would care because the article highlights both analyst price targets and positive earnings estimate revisions as indicators of possible stock upside.
The 14 Wall Street analysts covering MKS, Inc. have a median 12-month price target of $425, with estimates ranging from $270 to $600. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering MKS, Inc., 12 rate it a Buy, 1 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks MKS, Inc. 90 out of 100 across roughly 4,600 US stocks as at 5 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 5 Sept 2026, MKS, Inc. ranks 90 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (98 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies +63.3% from the last close, and Ticker Nerd's factor model ranks MKS, Inc. 90 out of 100 as at 5 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering MKS, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MKSI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $270 to $600 over the next 12 months.
MKS, Inc. returned +157.0% over the 12 months to 4 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
MKS Inc. is a global technology company that provides foundational solutions for semiconductor manufacturing, electronics and packaging, and specialty industrial applications.
The most recent item we track (Zacks Investment Research, 4 Sept 2026): "Why Is MKS (MKSI) Down 14.3% Since Last Earnings Report?". MKS Instruments (MKSI) reported earnings 30 days ago, and its stock has declined 14.3% since that report. The article examines what might come next for the company's shares.
MKS Inc. is a global technology company that provides foundational solutions for semiconductor manufacturing, electronics and packaging, and specialty industrial applications. Its products and systems are used to measure, control, deliver, and monitor critical process parameters, supporting advanced manufacturing environments where precision and reliability are essential. The company also supplies photonics, vacuum, and materials technologies used across semiconductor fabrication, precision industrial processing, life and health sciences, research, and defense-related applications. MKS Inc. operates through three main business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions, giving it a broad role across process control, laser and optics applications, and surface treatment technologies. Headquartered in Andover, Massachusetts, MKS Inc. serves customers worldwide through a diversified portfolio of instruments, subsystems, systems, and specialty chemical offerings.
CEO Dr. John T. C. Lee Ph.D. · 10,200 employees · United States · https://www.mks.com
